July 28, 2009, Sibutramine Hydrochloride Capsules (strength: 10mg) produced by KRRP has won Drug Registration Certificate (License No.: HK-58124) approved by Hong Kong Pharmacy and Poisons Board in the sense that this product can be sold in Hong Kong market afterwards.

 

It is reported that Sibutramine Hydrochloride Capsules is the second successfully registered product in Hong Kong in the wake of Nicergoline Tablets, which symbolizes a further step of KRRP in internationalization process. It cannot do without the diligent workings of all colleagues in Tech(Ops) Department and buttressing of company management. Success of the registration has greatly encouraged all staffs in KRRP, every one of whom is bound to uphold the annual theme of “Exploit & Expand” and work together to create new resplendence of KRRP!